From October 1, 2021 to December 31, 2021, the company has repurchased 44,857 shares, representing 0.39% for KRW 435.14 million. With this, the company has completed the repurchase of 44,857 shares, representing 0.39% for KRW 435.14 million under the buyback announced on March 27, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,420 KRW | -0.80% |
|
-2.88% | -21.15% |
1st Jan change | Capi. | |
---|---|---|
-21.15% | 60.83M | |
+19.51% | 42.97B | |
+24.56% | 22.16B | |
+19.29% | 15.45B | |
+20.33% | 14.56B | |
+55.51% | 13.03B | |
-0.05% | 6.79B | |
-11.35% | 6.46B | |
+17.73% | 5.87B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- A001540 Stock
- News Ahn-Gook Pharmaceutical Co., Ltd.
- Tranche Update on Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2020.